David B. Friedman

Papers

Total Citations

H-Index

About

David B. Friedman is a distinguished proteomics researcher whose work centers on the development and application of advanced mass spectrometry and gel electrophoresis techniques to unravel complex biological signaling networks. His major contributions include pioneering the use of multivariable difference gel electrophoresis (DIGE) coupled with mass spectrometry to simultaneously track changes in protein expression and post-translational modifications. In his highly cited 2006 study, Friedman applied this innovative approach to investigate how transforming growth factor-β (TGF-β) receptor activation alters the proteome in MCF10A mammary epithelial cells overexpressing the HER2/Neu (ErbB2) oncogene—a critical model for understanding breast cancer progression. This work, which has garnered over 40 citations, exemplifies his ability to bridge cutting-edge analytical methods with fundamental questions in cell signaling and oncology. Friedman’s research has provided vital insights into the molecular mechanisms driving cancer, establishing him as a key figure in quantitative proteomics and its application to disease biology.